Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tylenol GoTabs

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare announces the launch of Extra Strength Tylenol GoTabs, the first-ever adult chewable Tylenol tablets Oct 3. The chewable tablets, available in spearmint ice flavor, are the "ideal solution for travelers, especially airline passengers unsure about what forms of medication are permitted on commercial flights, drivers stuck in traffic or commuters dealing with train and bus delays," the firm says. The six-count blister packs are small enough to "slip easily into a jacket pocket, briefcase or purse," the release adds. TSA announced in August it loosened up restrictions on liquids, allowing four ounces of non-prescription liquid medications on board (1"The Tan Sheet" Aug. 21, 2006, In Brief)...

You may also be interested in...

OTCs in carry-ons

Four ounces of non-prescription liquid medications, up to five ounces of low blood sugar treatments and small amounts of breast milk and baby formula will be allowed in carry-on bags according to the new TSA security procedures issued Aug. 13. Breast milk and baby formula will only be allowed if a passenger is traveling with a baby or toddler. All items including medication will be x-rayed unless a passenger asks for visual inspection...

P&G Health, Hygiene Brands Ride Consumer ‘Trust’ To Sales Growth Amid Pandemic Uncertainty

“There’s a heightened need for products that deliver against health, hygiene and clean home concerns and a willingness to spend just a little bit more to ensure that I’m using a product that I know and trust,” says CFO Jon Moeller 

Asia Deal Watch: Rhizen Licenses Chinese Rights For PI3K Inhibitor To Curon

Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts